The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
he looked at Alzheimer's and um and healthy controls he looked at their plasma and he has looked at using proteomics looking at different proteins which which are their story and normal age and what he found I think the most striking finding was normal itching he found um I think 30 plus proteins in the plasma that were elevated with normal aging that were related to blevant barrier
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.